Lerman C - Search Results

1

Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.

Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW Jr, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF; PGRN-PNAT Research Group. Chenoweth MJ, et al. Among authors: lerman c. Addiction. 2018 Mar;113(3):509-523. doi: 10.1111/add.14032. Epub 2017 Nov 2. Addiction. 2018. PMID: 28921760 Free PMC article.

2

Nicotine metabolism and CYP2D6 phenotype in smokers.

Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ, Utermahlan B, Falk RT, Shields P. Caporaso NE, et al. Among authors: lerman c. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):261-3. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303596 Clinical Trial.

3

Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.

Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Lerman C, et al. Nicotine Tob Res. 2001 Nov;3(4):353-9. doi: 10.1080/14622200110072156. Nicotine Tob Res. 2001. PMID: 11694203 Clinical Trial.

4

Mediating mechanisms for the impact of bupropion in smoking cessation treatment.

Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Lerman C, et al. Drug Alcohol Depend. 2002 Jul 1;67(2):219-23. doi: 10.1016/s0376-8716(02)00067-4. Drug Alcohol Depend. 2002. PMID: 12095672 Clinical Trial.

5

Pharmacogenetic investigation of smoking cessation treatment.

Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Lerman C, et al. Pharmacogenetics. 2002 Nov;12(8):627-34. doi: 10.1097/00008571-200211000-00007. Pharmacogenetics. 2002. PMID: 12439223 Clinical Trial.

6

Dopamine transporter genotype as a risk factor for obesity in African-American smokers.

Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, Hawk L, Wileyto EP, Shields PG, Lerman C. Epstein LH, et al. Among authors: lerman c. Obes Res. 2002 Dec;10(12):1232-40. doi: 10.1038/oby.2002.168. Obes Res. 2002. PMID: 12490667 Free article.

7

Individual differences in nicotine intake per cigarette.

Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. Patterson F, et al. Among authors: lerman c. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):468-71. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12750245

8

Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain.

Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. Miksys S, et al. Among authors: lerman c. Neuropharmacology. 2003 Jul;45(1):122-32. doi: 10.1016/s0028-3908(03)00136-9. Neuropharmacology. 2003. PMID: 12814665

9

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.

Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Collins BN, et al. Among authors: lerman c. Nicotine Tob Res. 2004 Feb;6(1):27-37. doi: 10.1080/14622200310001656830. Nicotine Tob Res. 2004. PMID: 14982685 Clinical Trial.

10

Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.

Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. Lerman C, et al. Ann Intern Med. 2004 Mar 16;140(6):426-33. doi: 10.7326/0003-4819-140-6-200403160-00009. Ann Intern Med. 2004. PMID: 15023708 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page